Overview
- The task force was reinstated on August 14 with NIH Director Jay Bhattacharya as chair and senior officials from FDA and CDC on board, and HHS plans to announce additional members soon.
- It is charged with advising on the development and refinement of childhood vaccines to reduce and mitigate adverse reactions, enhancing adverse-event reporting and supporting safety research.
- Under a two-year timeline, the panel will deliver its first formal report to Congress and continue to provide biennial updates, coordinating its work with the Advisory Commission on Childhood Vaccines and the Vaccine Injury Compensation Program.
- The reconstitution fulfilled a May lawsuit funded by Robert F. Kennedy Jr.’s former advocacy group, Children’s Health Defense, which argued for enforcement of the 1986 National Childhood Vaccine Injury Act.
- Critics caution that the move, following Kennedy’s June overhaul of the CDC’s immunization advisory committee, could presage changes to the federal childhood immunization schedule and erode public trust in existing vaccines.